AlphAIAlphAI — Financial news for AI agents
finance.yahoo.comOCT 301 min read$CL

Colgate-Palmolive (NYSE:CL) posts better-than-expected sales in Q3 2026, stock soars

Colgate-Palmolive reported Q3 2026 revenue of $5.37 billion, exceeding estimates by $0.03 billion and growing 4.6% year-on-year. Adjusted EPS of $0.97 beat estimates by $0.04. Operating margin remained steady at 20.3%, but free cash flow margin declined to 19.3%. Organic revenue and sales volumes grew 3.6% and 1.7%, respectively.

Original reporting
finance.yahoo.com
Published Oct 30, 2026, 1:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 30, 2026, 1:17 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Colgate-Palmolive (NYSE:CL) posts better-than-expected sales in Q3 2026, stock soars — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$CLBullishHigh
01

Why it matters

The earnings beat is likely to attract short‑term buying, supporting further price appreciation.

02

Market read

Strong earnings for a large‑cap consumer staple can lift the sector and reinforce bullish sentiment.

03

What to watch

Potential margin pressure from higher input costs despite revenue growth.

Relevance 9/10Novelty 9/10Timing: post-market today

Background

Colgate-Palmolive's Q3 2026 earnings were released, showing modest year‑on‑year growth and beats on revenue and EPS.

Company-level read

Ticker impact

$CLBullishHigh confidence
Context

Colgate-Palmolive reported Q3 2026 revenue and EPS beats, driving a sharp stock rally.

Expected impact

upward pressure as investors price in better-than-expected sales and earnings.

Evidence & confidence

The beat on both revenue and adjusted EPS, combined with a share price surge, signals fresh buying interest.

Market effects

Sector

Consumer staples may see modest upside as a major player reports strong demand.

Regional

U.S. consumer goods sector gains momentum.

Global

Limited to markets tracking U.S. consumer staples.

Counterpoint

What could challenge this read

If the beat is already priced in, the rally could be short-lived.

Key entities

  • company
    Colgate-Palmolive

    Consumer staples manufacturer reporting Q3 2026 results.

Read at source← All news

StoryColgate-Palmolive posts Q3 2026 beat and raises full‑year Base Business EPS outlook

Also covered by

4 outlets

Related articles

NOV 2
$CLMed

BofA raises Colgate-Palmolive stock price target to $105 on earnings

BofA Securities raised its price target for Colgate-Palmolive (NYSE:CL) to $105 from $100, citing strong earnings and updated fiscal 2026 guidance. The company reported Q3 earnings of $0.97 per share, exceeding estimates, with revenue of $5.37 billion. Colgate updated its outlook, expecting 4% to 5% net sales growth and 5% to 7% earnings growth. Analysts from UBS and Wells Fargo also raised their price targets.

investing.com2 min
NOV 2
$CLMedAI 8/10

Wells Fargo raises Colgate-Palmolive stock price target on solid Q3

Wells Fargo raised its price target for Colgate-Palmolive (NYSE:CL) to $95 from $90, citing solid Q3 2026 results. The firm noted strong performance despite macroeconomic challenges and inflation. CL's P/E ratio is 37.77, and it is considered overvalued. Q3 earnings beat expectations with $0.97 EPS on $5.37B revenue. UBS also raised its target to $112, highlighting strong margins.

investing.com2 min
NOV 2
$CLMed

UBS raises Colgate-Palmolive stock price target on margin strength

UBS raised its price target for Colgate-Palmolive (CL) to $112 from $106, citing strong Q3 earnings, revenue, and margins. The company beat EPS estimates and raised 2026 guidance. UBS expects continued sales growth despite inflation and FX headwinds, though the stock is slightly overvalued. CL reported Q3 adjusted EPS of $0.97 on revenue of $5.37B, exceeding expectations.

investing.com1 min
NOV 1
$CLMed

Colgate-Palmolive Co (CL) (Q3 2026) Earnings Call Highlights: Broad-Based Organic

Colgate-Palmolive (CL) reported Q3 2026 earnings, highlighting 6.5% organic growth in Hills pet food and strong volume leverage. CEO Noel Wallace attributed margin gains to pricing, innovation, and ad spend efficiency. CFO Stan Sutula noted material cost headwinds offset by productivity and pricing. Latin America grew 6%, with Brazil up double-digits. US toothpaste showed slight improvement, with more pricing expected.

finance.yahoo.com2 min
OCT 30
$CLHighAI 8/10

Colgate-Palmolive Company Q3 2026 Earnings Call Summary

Colgate-Palmolive reported Q3 2026 earnings, highlighting organic growth in emerging markets and Europe. Gross margin expansion was driven by pricing strategy and manufacturing leverage. The company is transitioning its U.S. go-to-market structure and integrating AI for revenue growth. Hill's Pet Nutrition saw strong performance in high-growth segments.

finance.yahoo.com3 min
OCT 30
$CLHighAI 8/10

Colgate-Palmolive Q3 Earnings Call Highlights

Colgate-Palmolive (CL) reported Q3 earnings, noting elevated commodity and logistics costs. Hill's Pet Nutrition saw 6.5% organic sales growth, driven by cat food and wet food. U.S. toothpaste market share shows early improvement. Latin America grew 6%, with Brazil up double digits. Asia-Pacific rose 5%, led by India. Full-year cost inflation is estimated at $300M. The company plans to provide 2027 guidance in Q1 next year.

finance.yahoo.com3 min